Results 1 to 10 of about 27,755 (279)

Gesso / Gips

1985
openaire   +1 more source

Chromatographie an Gips

Fresenius' Zeitschrift für analytische Chemie, 1967
openaire   +1 more source

gIP-10

2012
openaire   +1 more source

Gips m

2013
openaire   +1 more source

Paarden in gips

APm: Allard Pierson mededelingen, 2012
openaire   +1 more source

GIP-derived GIP receptor antagonists – a review of their role in GIP receptor pharmacology

Peptides
Surprisingly, agonists, as well as antagonists of the glucose-dependent insulinotropic polypeptide receptor (GIPR), are currently being used or investigated as treatment options for type 2 diabetes and obesity - and both, when combined with glucagon-like peptide 1 receptor (GLP-1R) agonism, enhance GLP-1-induced glycemia and weight loss further.
Rosenkilde, Mette Marie, Lindquist, Peter, Kizilkaya, Hüsün Sheyma, Gasbjerg, Lærke Smidt   +3 more
openaire   +4 more sources

Tirzepatide, GIP(1-42) and GIP(1-30) display unique signaling profiles at two common GIP receptor variants, E354 and Q354 [PDF]

Frontiers in Pharmacology
Type 2 diabetes (T2D) and obesity are prevalent metabolic disorders affecting millions of individuals worldwide. A new effective therapeutic drug called tirzepatide for the treatment of obesity and T2D is a dual agonist of the GIP receptor and GLP-1 ...
Tayla A. Rees, Tayla A. Rees, Tayla A. Rees, Benjamin J. Buttle, Zoe Tasma, Zoe Tasma, Sung-Hyun Yang, Paul W. R. Harris, Paul W. R. Harris, Paul W. R. Harris, Christopher S. Walker, Christopher S. Walker   +11 more
doaj   +3 more sources

Attenuated secretion of glucose-dependent insulinotropic polypeptide (GIP) does not alleviate hyperphagic obesity and insulin resistance in ob/ob mice

Molecular Metabolism, 2017
Objective: Glucose-dependent insulinotropic polypeptide (GIP) is released during meals and promotes nutrient uptake and storage. GIP receptor knockout mice are protected from diet induced weight gain and thus GIP antagonists have been proposed as a ...
Satoko Shimazu-Kuwahara, Norio Harada, Shunsuke Yamane   +2 more
exaly   +3 more sources

The evolution of the therapeutic concept ‘GIP receptor antagonism’ [PDF]

Frontiers in Endocrinology
Glucose-dependent insulinotropic polypeptide (GIP) is an intestinal hormone that potentiates glucose-induced insulin secretion in the postprandial state. GIP exerts a broad range of other physiological actions e.g.
Frederikke Koefoed-Hansen, Frederikke Koefoed-Hansen, Mads Marstrand Helsted, Hüsün Sheyma Kizilkaya, Asger Bach Lund, Asger Bach Lund, Asger Bach Lund, Mette Marie Rosenkilde, Lærke Smidt Gasbjerg, Lærke Smidt Gasbjerg   +9 more
doaj   +3 more sources

Association between plasma glucose-dependent insulinotropic polypeptide and active adiponectin in normoglycemic women [PDF]

Endocrine Connections
Background/objectives: Glucose-dependent insulinotropic polypeptide (GIP) is secreted by enteroendocrine K cells in response to nutrient ingestion. The aims of this study were: i) to evaluate the cross-sectional associations between plasma GIP change in ...
Isidora Salvatierra, Javier Parada, Rodrigo Cataldo, José Eduardo Galgani, Gigliola Alberti, Idoia Labayen, José L Santos   +6 more
doaj   +2 more sources